Committee Discusses US Leadership in Biomedical Innovation, Members Highlight Need for Change to FDA Regulatory Frameworks
		October 30, 2025 |  | 	
Committee Discusses US Leadership in Biomedical Innovation, Members Highlight Need for Change to FDA Regulatory Frameworks
The Senate Committee on Health, Education, Labor, and Pensions (HELP) held a hearing to discuss the future of biotechnology and the steps needed to maintain U.S. leadership in biomedical innovation. The hearing focused on ensuring continued innovation and increased competitiveness in the American biotechnology space, while also maintaining high standards for safety and affordability. Witnesses and members discussed and widely agreed on… (Ray, October 30, 2025) #Drug Pricing, #Food and Drug Administration, #Pharmacy Benefit Managers, #Prescription Drugs
 
				